Champions Oncology Inc (CSBR) Stock Analysis

Champions Oncology Inc (CSBR) is a publicly traded company in the HEALTHCARE sector. It trades at $5.84, carries a market capitalization of $81.10M. This page summarizes the public market data, fundamentals, and frequently asked questions for CSBR, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Champions Oncology Inc currently has a Neutral sentiment score of 0.07.

About Champions Oncology Inc

Champions Oncology, Inc. (CSBR) is a leading innovator in the field of cancer therapy, headquartered in Hackensack, New Jersey. The company specializes in developing advanced technology solutions that enhance the efficacy and personalization of oncology treatments. By leveraging proprietary tumor models and sophisticated data analytics, Champions Oncology enables pharmaceutical partners and researchers to create tailored drug development strategies, significantly improving patient outcomes. A...

GNG Research Analysis

GNG Research scores Champions Oncology Inc (CSBR) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for CSBR.

Frequently Asked Questions

Does CSBR pay dividends?

Champions Oncology Inc (CSBR) does not currently pay a regular dividend.

What is CSBR's market cap?

Champions Oncology Inc (CSBR) has a market capitalization of $81.10M with a current stock price of $5.84.